Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter (GUARD)

ClinicalTrials.gov ID: NCT06872684

Public ClinicalTrials.gov record NCT06872684. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 27, 2026, 1:22 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms With Surpass Elite With GUARDian Flow Diverter

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of the Safety and Efficacy of Endovascular Treatment of Intracranial Aneurysms with Surpass Elite with GUARDian Flow Diverter (GUARD) trial is to evaluate the safety and efficacy of the Surpass Elite with Guardian Flow Diverter System (FDS) in the treatment of unruptured, wide-neck saccular or fusiform, intracranial aneurysms (IAs) located on the internal carotid artery (ICA) or its branches.

Study identification

NCT ID: NCT06872684
Recruitment status: Recruiting
Study type: Interventional
Phase: Not applicable
Lead sponsor: Stryker Neurovascular; Industry
Enrollment: 183 participants

Conditions and interventions

Conditions

Interventions

Surpass Elite with Guardian Flow Diverter System Device

Device

Eligibility (public fields only)

Age range: 18 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jun 20, 2025 (Actual)
Primary completion: Jan 31, 2029 (Estimated)
Completion: Jan 31, 2031 (Estimated)
Last update posted: Oct 21, 2026

2025 – 2031

United States locations

U.S. sites: 20
U.S. states: 14
U.S. cities: 20

Facility	City	State	ZIP	Site status
Carondelet St. Joseph's Hospital	Tucson	Arizona	85711	Recruiting
University of California Davis Health	Davis	California	95616	Recruiting
University of California Los Angeles (UCLA)	Los Angeles	California	90095	Recruiting
Stanford University School of Medicine	Palo Alto	California	94304	Recruiting
Lyerly Neurosurgery, an Affiliate of Baptist	Jacksonville	Florida	32207	Recruiting
Baptist Hospital of Miami	Miami	Florida	33176	Recruiting
Indiana University	Indianapolis	Indiana	46202	Recruiting
University of Iowa Healthcare	Iowa City	Iowa	52242	Recruiting
University of Kansas Medical Center	Kansas City	Kansas	66160	Recruiting
Lahey Hospital and Medical Center	Burlington	Massachusetts	01803	Recruiting
Robert Wood Johnson University Medical Center	New Brunswick	New Jersey	08901	Recruiting
Mount Sinai Health System	New York	New York	10029	Recruiting
University of Rochester Medical Center	Rochester	New York	14618	Recruiting
Stony Brook University Hospital	Stony Brook	New York	11794	Recruiting
Montefiore Medical Center	The Bronx	New York	10467	Recruiting
Cleveland Clinic	Cleveland	Ohio	44195	Recruiting
Oregon Health & Science University	Portland	Oregon	97239	Recruiting
University of Pennsylvania	Philadelphia	Pennsylvania	19104	Recruiting
Semmes Murphey	Memphis	Tennessee	38120	Recruiting
The University of Texas Medical Branch at Galveston	Galveston	Texas	77555	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06872684, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 21, 2026 · Synced Oct 27, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06872684 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →